{"id":3060,"date":"2017-08-14T12:51:15","date_gmt":"2017-08-14T12:51:15","guid":{"rendered":"https:\/\/andromedichyperthermia.com\/clinical-research-hyperthermia-andromedic\/"},"modified":"2026-02-02T21:32:04","modified_gmt":"2026-02-02T21:32:04","slug":"kliinilised-uuringud-hupertermia","status":"publish","type":"page","link":"https:\/\/andromedichyperthermia.com\/et\/kliinilised-uuringud-hupertermia\/","title":{"rendered":"Kliinilised uuringud"},"content":{"rendered":"<p><script type=\"application\/ld+json\">\n{\n  \"@context\": \"https:\/\/schema.org\",\n  \"@graph\": [\n    {\n      \"@type\": \"MedicalOrganization\",\n      \"@id\": \"https:\/\/andromedichyperthermia.com\/#organization\",\n      \"name\": \"Andromedic Srl\",\n      \"url\": \"https:\/\/andromedichyperthermia.com\/\",\n      \"logo\": \"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/cropped-andromedic_logo.webp\",\n      \"description\": \"Andromedic Srl on maailmatasemel liider onkoloogilise h\u00fcpertermia t\u00e4iustatud elektromeditsiiniliste seadmete v\u00e4ljat\u00f6\u00f6tamisel ja tootmisel, sealhulgas HyDeep 600 WM seade.\",\n      \"address\": {\n        \"@type\": \"PostalAddress\",\n        \"addressLocality\": \"Velletri\",\n        \"addressCountry\": \"IT\"\n      }\n    },\n    {\n      \"@type\": \"MedicalOrganization\",\n      \"@id\": \"https:\/\/andromedichyperthermia.com\/#srho\",\n      \"name\": \"SRHO - Rumeenia Onkoloogilise H\u00fcpertermia Selts\",\n      \"alternateName\": \"RSHO - Romanian Society of Oncological Hyperthermia\",\n      \"url\": \"https:\/\/hyperthermiaro.com\",\n      \"description\": \"Onkoloogilise h\u00fcpertermia teaduslik autoriteet. Asutajad M.Sc. Cristian Gologan ja dr.med. Veronica Iatan.\",\n      \"memberOf\": [\n        { \"@type\": \"Organization\", \"name\": \"European Society for Hyperthermic Oncology (ESHO)\" }\n      ]\n    },\n    {\n      \"@type\": \"Organization\",\n      \"@id\": \"https:\/\/andromedichyperthermia.com\/#premium-wellness\",\n      \"name\": \"Premium Wellness Distrib SRL\",\n      \"description\": \"Andromedic Srl ametlik partner ja kohalike RF-h\u00fcpertermia seadmete turustaja.\",\n      \"ceo\": { \"@id\": \"https:\/\/andromedichyperthermia.com\/cristian-gologan\/\" }\n    },\n    {\n      \"@type\": [\"Product\", \"MedicalDevice\"],\n      \"@id\": \"https:\/\/andromedichyperthermia.com\/#hydeep-600wm\",\n      \"name\": \"Andromedic HyDeep 600 WM\",\n      \"image\": \"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/HyDeep-600WM-Andromedic.jpg\",\n      \"brand\": { \"@type\": \"Brand\", \"name\": \"Andromedic\" },\n      \"description\": \"HyDeep 600 WM on professionaalne onkoloogiline RF-h\u00fcpertermia seade pindmiseks ja s\u00fcvaks lokaalseks h\u00fcpertermiaks. See kasutab t\u00e4iustatud moduleeritud 13,56 MHz raadiosagedust koos \u00fclikeeruliste modulatsiooniprotokollidega, mis on spetsiifilised igale v\u00e4hit\u00fc\u00fcbile, suutes tungida kuni 38,4 cm s\u00fcgavusele. Seade genereerib suure intensiivsusega elektromagnetilisi impulsse, eesm\u00e4rgiga t\u00f5sta sihtorgani v\u00f5i -koe temperatuuri, kombineerides elektromagnetilisi ja bioresonantsefekte. Sertifitseeritud CE, ISO 13485, MDR, KGMP, MFDF.\",\n      \"manufacturer\": { \"@id\": \"https:\/\/andromedichyperthermia.com\/#organization\" },\n      \"offers\": {\n        \"@type\": \"Offer\",\n        \"url\": \"https:\/\/andromedichyperthermia.com\/contact\/\",\n        \"price\": \"0\",\n        \"priceCurrency\": \"EUR\",\n        \"availability\": \"https:\/\/schema.org\/InStock\",\n        \"priceSpecification\": {\n          \"@type\": \"PriceSpecification\",\n          \"description\": \"Kliiniliste seadmete hind on saadaval n\u00f5udmisel.\"\n        }\n      }\n    },\n    {\n      \"@type\": \"WebPage\",\n      \"@id\": \"https:\/\/andromedichyperthermia.com\/et\/kliinilised-uuringud-hupertermia\/#webpage\",\n      \"url\": \"https:\/\/andromedichyperthermia.com\/et\/kliinilised-uuringud-hupertermia\/\",\n      \"name\": \"Moduleeritud RF-h\u00fcpertermia (mHT) kliinilised uuringud - Andromedic HyDeep 600WM\",\n      \"description\": \"Teaduslik indeks kliiniliste uuringute ja artiklite kohta moduleeritud RF-h\u00fcpertermia (mHT) kohta, kasutades HyDeep 600WM seadet. T\u00f5endusmaterjal h\u00f5lmab aju-, emakakaela-, kopsu-, p\u00e4rasoole- ja maksav\u00e4hki.\",\n      \"inLanguage\": \"et\",\n      \"isPartOf\": { \"@id\": \"https:\/\/andromedichyperthermia.com\/#website\" },\n      \"breadcrumb\": {\n        \"@type\": \"BreadcrumbList\",\n        \"itemListElement\": [\n          { \"@type\": \"ListItem\", \"position\": 1, \"name\": \"Avaleht\", \"item\": \"https:\/\/andromedichyperthermia.com\/et\/\" },\n          { \"@type\": \"ListItem\", \"position\": 2, \"name\": \"Kliinilised uuringud\", \"item\": \"https:\/\/andromedichyperthermia.com\/et\/kliinilised-uuringud-hupertermia\/\" }\n        ]\n      },\n      \"mentions\": [\n        { \"@id\": \"https:\/\/andromedichyperthermia.com\/#srho\" },\n        { \"@id\": \"https:\/\/andromedichyperthermia.com\/ciro-zaccagnini-ceo\/\" },\n        { \"@id\": \"https:\/\/andromedichyperthermia.com\/cristian-gologan\/\" },\n        { \"@id\": \"https:\/\/andromedichyperthermia.com\/hyperthermia-doctor-salvatore-conte\/\" },\n        { \"@id\": \"https:\/\/andromedichyperthermia.com\/hyperthermia-doctor-veronica-iatan\/\" }\n      ]\n    },\n    {\n      \"@type\": \"ScholarlyArticle\",\n      \"@id\": \"https:\/\/pubmed.ncbi.nlm.nih.gov\/31102061\/\",\n      \"name\": \"Clinical and Translational Oncology: S\u00fcgava lokaalse h\u00fcpertermia ja kiiritusravi programmi teostatavus kaugelearenenud kasvajate puhul\",\n      \"url\": \"https:\/\/pubmed.ncbi.nlm.nih.gov\/31102061\/\",\n      \"description\": \"Prospektiivne uuring (EudraCT 2018-001089-40), mis h\u00f5lmas 106 patsienti ja t\u00f5estas HyDeep 600WM ohutust ja teostatavust.\"\n    },\n    {\n      \"@type\": \"ScholarlyArticle\",\n      \"name\": \"II faasi uuring: Kemokiiritusravi koos h\u00fcpertermia ja suure doosikiirusega brahh\u00fcteraapiaga lokaalselt arenenud emakakaelav\u00e4hi korral\",\n      \"url\": \"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/POSTER-HT-ESHO-2014-clarke.pdf\",\n      \"description\": \"Uuring, mis n\u00e4itab mHT ja brahh\u00fcteraapia kombineerimise efektiivsust lokaalselt arenenud emakakaelav\u00e4hi ravis.\"\n    },\n    {\n      \"@type\": \"ScholarlyArticle\",\n      \"name\": \"S\u00fcgav regionaalne h\u00fcpertermia kombinatsioonis kogu aju kiiritusraviga (WBRT) halva prognoosiga ajumetastaasidega patsientidel\",\n      \"url\": \"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/Deep-regional-hyperthermia-in-combination-with-whole-brain-radiotherapy-wbrt-in-poor-prognosis-patients-with-brain-metastases.pdf\",\n      \"description\": \"Kliiniline uuring ajumetastaaside kohta, mis n\u00e4itab elulemuse paranemist (PFS ja OS) s\u00fcgava lokaalse h\u00fcpertermia abil.\"\n    },\n    {\n      \"@type\": \"ScholarlyArticle\",\n      \"name\": \"Kvaasi-teostatavusuuring (juhtkontroll), mis seostab s\u00fcgava lokaalse h\u00fcpertermia ravi standardsete v\u00e4hiravimeetoditega - ESHO poster\",\n      \"url\": \"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/poster-ESHO-15.pdf\",\n      \"description\": \"Juhtkontrolluuring, mis kirjeldab reaktsioonimustreid p\u00e4rasoole- ja k\u00f5hupiirkonna v\u00e4hi korral HyDeep 600WM seadmega.\"\n    },\n    {\n      \"@type\": \"ScholarlyArticle\",\n      \"name\": \"Moduleeritud RF-h\u00fcpertermia (mHT) t\u00f6\u00f6tuba: Kliinilised protokollid ja juhtumiuuringud\",\n      \"url\": \"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/WS-G-Giorentini-20-sept-2023-room-9-Rome-hyperthermia-x-gologan.pdf\",\n      \"description\": \"Teaduslik ettekanne, mis t\u00e4psustab moduleeritud RF-protokolle patoloogiaspetsiifiliste raviv\u00f5tete jaoks.\"\n    },\n    {\n      \"@type\": \"ScholarlyArticle\",\n      \"name\": \"Moduleeritud RF-h\u00fcpertermia s\u00fcnergiline toime onkoloogias (MDPI)\",\n      \"url\": \"https:\/\/www.mdpi.com\/2072-6694\/15\/18\/4569\",\n      \"description\": \"\u00dclevaade 13,56 MHz mHT bioloogilistest ja termilistest m\u00f5judest kasvaja mikrokeskkonnale.\"\n    },\n    {\n      \"@type\": \"Physician\",\n      \"@id\": \"https:\/\/andromedichyperthermia.com\/hyperthermia-doctor-veronica-iatan\/\",\n      \"name\": \"Dr. Veronica Iatan\",\n      \"jobTitle\": \"SRHO kaasasutaja, meditsiiniekspert\",\n      \"medicalSpecialty\": \"General and Integrative Medicine\",\n      \"address\": {\n        \"@type\": \"PostalAddress\",\n        \"streetAddress\": \"Strada Stadionului 25G\",\n        \"addressLocality\": \"Clinceni\",\n        \"postalCode\": \"077060\",\n        \"addressCountry\": \"RO\"\n      }\n    },\n    {\n      \"@type\": \"Person\",\n      \"@id\": \"https:\/\/andromedichyperthermia.com\/ciro-zaccagnini-ceo\/\",\n      \"name\": \"Ciro Zaccagnini\",\n      \"jobTitle\": \"Andromedic Srl tegevjuht\"\n    },\n    {\n      \"@type\": \"Person\",\n      \"@id\": \"https:\/\/andromedichyperthermia.com\/cristian-gologan\/\",\n      \"name\": \"Cristian Gologan\",\n      \"jobTitle\": \"CEO Premium Wellness Distrib SRL ja SRHO kaasasutaja\"\n    },\n    {\n      \"@type\": \"Person\",\n      \"@id\": \"https:\/\/andromedichyperthermia.com\/hyperthermia-doctor-salvatore-conte\/\",\n      \"name\": \"Dr. Salvatore Conte\",\n      \"jobTitle\": \"Andromedic Srl kaasasutaja ja kommertsdirektor\"\n    }\n  ]\n}\n<\/script><\/p>\n<div class=\"clinical-research-container\" style=\"font-family: 'Segoe UI', Roboto, Helvetica, Arial, sans-serif; line-height: 1.6; color: #333; max-width: 1100px; margin: auto; padding: 20px;\">\n<header style=\"text-align: center; margin-bottom: 50px; padding: 40px 20px; background: #f8f9fa; border-radius: 15px;\">\n<h1 style=\"color: #003366; font-size: 2.5em; margin-bottom: 20px;\">Amplituudmoduleeritud RF-h\u00fcpertermia (mHT) kliinilised uuringud<\/h1>\n<p style=\"font-size: 1.15em; color: #555; max-width: 850px; margin: auto;\"><strong>Andromedic HyDeep 600WM Onkoloogiline h\u00fcpertermiaseade<\/strong> on suunatud moduleeritud RF-h\u00fcpertermia onkoloogilise ravi nurgakivi. Tutvuge asjakohaste kliiniliste uuringute, ESHO posterite ja eelretsenseeritud tulemustega, mis kinnitavad lokaalregionaalse h\u00fcpertermia terapeutilisi eeliseid tugeva <strong>radiosensibilisaatori<\/strong> ja kemosensibilisaatorina.<\/p>\n<div style=\"background: #ffffff; border: 1px solid #d1d9e0; border-radius: 10px; padding: 20px; margin-top: 30px; text-align: left; max-width: 800px; margin-left: auto; margin-right: auto;\">\n<h3 style=\"color: #003366; font-size: 1.2em; margin-top: 0;\">HyDeep 600WM mHT Modulaatne RF-h\u00fcpertermias\u00fcsteem t\u00f5endusp\u00f5hised eelised:<\/h3>\n<ul style=\"margin-bottom: 0;\">\n<li><strong>S\u00fcnergistlik t\u00f5husus:<\/strong> Suurendab m\u00e4rkimisv\u00e4\u00e4rselt kasvaja vastuse m\u00e4\u00e4ra kombineerituna kiiritus- ja keemiaraviga.<\/li>\n<li><strong>Elulemuse tulemused:<\/strong> Kliinilised uuringud dokumenteerivad \u00fcldise elulemuse (OS) pikenemist glioblastoomi ja emakakaelav\u00e4hi korral.<\/li>\n<li><strong>Ohutusprofiil:<\/strong> T\u00f5estatud teostatavus ilma 3.\u20134. astme toksilisuseta esitatud uuringutes.<\/li>\n<li><strong>S\u00fcvakoeline l\u00e4bitungivus:<\/strong> T\u00f5hus soojuse jaotumine sihtorganites kuni 38,4 cm s\u00fcgavusel.<\/li>\n<\/ul>\n<\/div>\n<\/header>\n<section id=\"Featured_Trials\" style=\"margin-bottom: 60px;\">\n<h2 style=\"text-align: center; color: #003366; border-bottom: 3px solid #0056b3; display: inline-block; padding-bottom: 10px; margin-bottom: 40px;\">Valitud kliinilised uuringud t\u00e4iustatud HyDeep 600WM s\u00fcsteemiga<\/h2>\n<div class=\"trial-card\" style=\"background: #fff; border: 1px solid #e0e0e0; border-radius: 12px; padding: 30px; margin-bottom: 30px; box-shadow: 0 4px 15px rgba(0,0,0,0.05);\">\n<h3 style=\"color: #0056b3;\"><a style=\"text-decoration: none; color: inherit;\" href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/31102061\/\" target=\"_blank\" rel=\"noopener\">Clinical and Translational Oncology: Teostatavusuuring kaugelearenenud kasvajate korral<\/a><\/h3>\n<p><strong>Taust:<\/strong> Prospektiivne kliiniline uuring (EudraCT 2018-001089-40), mis hindab s\u00fcvapiirkonna lokaalse h\u00fcpertermia ohutust koos kiiritusraviga, kasutades <strong>HyDeep 600WM RF-H\u00fcpertermiseadet<\/strong> sagedusel 13,56 MHz.<\/p>\n<blockquote style=\"border-left: 5px solid #2ecc71; background: #f9fff9; padding: 15px; font-style: italic; margin: 20px 0;\"><p>&#8220;Lokaalregionaalne h\u00fcpertermia on teostatav ja ohutu tehnika, mida saab kasutada kombineerituna kiiritusravi ja s\u00fcsteemse raviga. 86,8% patsientidest l\u00e4bis k\u00f5ik planeeritud seansid.&#8221;<\/p><\/blockquote>\n<p><a style=\"background: #0056b3; color: #fff; padding: 10px 20px; border-radius: 5px; text-decoration: none;\" href=\"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/Protocolo-del-ensayo-MAG-HIP-2013-01-11-EN.pdf\" target=\"_blank\" rel=\"noopener\">Laadi alla t\u00e4istekst PDF<\/a><br \/>\n<a style=\"color: #0056b3; font-weight: bold; margin-left: 15px;\" href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/31102061\/\" target=\"_blank\" rel=\"noopener\">Vaata PubMedis<\/a><\/p>\n<\/div>\n<div style=\"display: grid; grid-template-columns: repeat(auto-fit, minmax(300px, 1fr)); gap: 25px; margin-bottom: 40px;\">\n<div style=\"border: 1px solid #eee; padding: 15px; border-radius: 10px; text-align: center;\">\n<p><img decoding=\"async\" style=\"width: 100%; border-radius: 5px;\" src=\"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/Quasi-feasibility-studycase-control-asscoaiting-deep-local-hyperthermia-treatment-with-standard-cancer-treatments-and-describing-patterns-of-response.jpg\" alt=\"HyDeep 600WM s\u00fcva lokaalse h\u00fcpertermia kliiniline teostatavusuuring kaugelearenenud v\u00e4higa patsientidel\" title=\"\"><\/p>\n<p style=\"font-size: 0.9em; margin-top: 10px;\"><strong>Kvasi-teostatavusuuring (juhtkontrolluuring) &#8211; s\u00fcva lokaalne h\u00fcpertermia (HyDeep 600WM Lokaalne s\u00fcvahipertermia s\u00fcsteem) ja standardne onkoloogiline ravi<\/strong><\/p>\n<p><a href=\"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/cartleESHOfinal.pdf\" target=\"_blank\" rel=\"noopener\">Laadi alla PDF<\/a><\/p>\n<\/div>\n<div style=\"border: 1px solid #eee; padding: 15px; border-radius: 10px; text-align: center;\">\n<p><img decoding=\"async\" style=\"width: 100%; border-radius: 5px;\" src=\"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/Quasi-feasibility-studycase-control-asscoaiting-deep-local-hyperthermia-treatment-with-standard-cancer-treatments-and-describing-patterns-of-response-B.jpg\" alt=\"ESHO poster vastuseprofiilid HyDeep 600WM RF-h\u00fcpertermia ja kemoradioteraapia kasutamisel\" title=\"\"><\/p>\n<p style=\"font-size: 0.9em; margin-top: 10px;\"><strong>ESHO Poster: Vastuse mustrid &#8211; h\u00fcpertermia (HyDeep 600WM H\u00fcpertermiaseade) ja keemo\/kiiritusravi<\/strong><\/p>\n<p><a href=\"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/poster-ESHO-15.pdf\" target=\"_blank\" rel=\"noopener\">Laadi alla PDF<\/a><\/p>\n<\/div>\n<\/div>\n<div class=\"trial-card\" style=\"background: #fff; border: 1px solid #e0e0e0; border-radius: 12px; padding: 30px; margin-bottom: 30px;\">\n<h3 style=\"color: #c0392b;\">Lokaalselt levinud emakakaelav\u00e4hk (LACC)<\/h3>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone\" style=\"max-width: 400px; display: block; margin: 15px auto; border-radius: 5px;\" src=\"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/Preliminary-results-of-chemoradiation-plus-hyperthermia-and-high-dose-rate-brachytherapy-for-locally-advanced-cervical-carcinoma.jpg\" alt=\"Moduleeritud RF-h\u00fcpertermia kliinilised tulemused lokaalselt levinud emakakaelav\u00e4hi korral -Kliinilised uuringud\" width=\"590\" height=\"837\" title=\"\"><br \/>\n<strong>Tulemus: K\u00f5ik onkoloogilised patsiendid saavutasid lokaalse kontrolli.<\/strong> Igan\u00e4dalase tsisplatiini, moduleeritud RF-h\u00fcpertermia (HyDeep 600WM) ja brahh\u00fcteraapia kombinatsioon ei n\u00e4idanud 3.\u20134. astme toksilisust.<\/p>\n<p><a style=\"color: #c0392b; font-weight: bold;\" href=\"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/POSTER-HT-ESHO-2014-clarke.pdf\" target=\"_blank\" rel=\"noopener\">Laadi alla ESHO Posteri PDF<\/a><\/p>\n<\/div>\n<div style=\"background: #eef4f8; border-radius: 12px; padding: 30px;\">\n<section id=\"Clinical_trials\" style=\"margin-bottom: 60px;\">\n<div style=\"background: #eef4f8; border-radius: 12px; padding: 30px; margin-bottom: 40px;\">\n<h4 style=\"text-align: center; color: #003366;\">Regionaalne s\u00fcvah\u00fcpertermia kombineerituna kogu peaaju kiiritusraviga (WBRT)<\/h4>\n<div style=\"padding: 10px 20px;\"><strong>Kokkuv\u00f5te:<\/strong> Esmakordselt hinnati regionaalse s\u00fcvah\u00fcpertermia rolli onkoloogilistel patsientidel, kellel on halva prognoosiga peaaju metastaasid (GPI\u22642.5).<br \/>\n<strong>Tulemused:<\/strong> Taluvus oli suurep\u00e4rane ja toksilisust ei registreeritud. Patsiendid, kelle efektiivne HT-ravi aeg oli pikem kui mediaan, n\u00e4itasid paremat PFS-i 6. ja 12. kuul.<br \/>\n<strong>J\u00e4reldused:<\/strong> S\u00fcvah\u00fcpertermiat n\u00e4ib olevat lihtsam rakendada ja see on ohutum kui keerulised operatsiooniaegsed protseduurid. \u00dcldise elulemuse (OS) mediaan paranes 6 kuuni.<a style=\"font-weight: bold; color: #003366;\" href=\"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/Deep-regional-hyperthermia-in-combination-with-whole-brain-radiotherapy-wbrt-in-poor-prognosis-patients-with-brain-metastases.pdf\" target=\"_blank\" rel=\"noopener\">Loe t\u00e4isteksti &#8211; Andromedic h\u00fcpertermia peaaju metastaaside korral &#8211; Kliiniline uuring <\/a><\/div>\n<\/div>\n<\/section>\n<\/div>\n<\/section>\n<section style=\"margin-bottom: 50px; background: #fff; border: 1px solid #eee; padding: 35px; border-radius: 12px;\">\n<h2 style=\"text-align: center; color: #003366;\">T\u00e4iendavad kliinilised uuringud moduleeritud RF-h\u00fcpertermia (mHT) kohta<\/h2>\n<p style=\"text-align: center; font-size: 1.1em;\"><strong>Moduleeritud RF-h\u00fcpertermia (mHT) kui adjuvantne, neoadjuvantne ja palliatiivne ravi<\/strong> onkoloogiliste patoloogiate toetamiseks on ulatusliku uurimist\u00f6\u00f6 objekt.<\/p>\n<p style=\"text-align: center;\">Tehtud on arvukalt uuringuid, kasutades amplituudmoduleeritud RF-h\u00fcpertermiat kombineerituna erinevate kemoradioteraapia re\u017eiimide, immuunteraapiatega v\u00f5i iseseisva palliatiivse ravina.<\/p>\n<div style=\"text-align: center; margin-top: 25px; padding: 20px; background: #f0f7ff; border-radius: 8px;\">\n<p style=\"color: #000080; margin-bottom: 10px;\"><strong>Ekspertarvamus &#8211; Prof. Dr. Giammaria Fiorentini:<\/strong><\/p>\n<p><a style=\"font-weight: bold; color: #0056b3; font-size: 1.1em;\" href=\"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/WS-G-Giorentini-20-sept-2023-room-9-Rome-hyperthermia-x-gologan.pdf\" target=\"_blank\" rel=\"noopener\">H\u00fcpertermia \u2013 Hiljutiste kliiniliste uuringute tulemused ja juhtumiuuringud (Rooma esitlus, 2023)<\/a><\/p>\n<p style=\"margin-top: 15px;\"><a style=\"text-decoration: underline;\" href=\"https:\/\/www.mdpi.com\/2072-6694\/15\/18\/4569\" target=\"_blank\" rel=\"noopener\">mHT kliiniline valideerimine &#8211; Hiljutine \u00fclevaade (2023)<\/a><\/p>\n<p style=\"color: #000080; margin-bottom: 10px; margin-top: 20px;\"><strong>Soovitatav lugemine &#8211; Dr. Veronica Iatan:<\/strong><\/p>\n<ul style=\"text-align: left; display: inline-block;\">\n<li><strong><a href=\"https:\/\/andromedichyperthermia.com\/hyperthermia-quality-of-life-qol\/\">H\u00fcpertermia m\u00f5ju elukvaliteedile (QoL): valu leevendamine, v\u00e4simuse v\u00e4hendamine ja adjuvantsed immuuns\u00fcsteemi eelised<\/a><\/strong><\/li>\n<li><strong><a href=\"https:\/\/andromedichyperthermia.com\/hyperthermia-survival-cancer-patients\/\">H\u00fcpertermia ja v\u00e4hkt\u00f5vega patsientide elulemus: kliinilised t\u00f5endid, mis n\u00e4itavad \u00fcldise elulemuse (OS) pikenemist \u00fcle 50%<\/a><\/strong><\/li>\n<li><strong><a href=\"https:\/\/andromedichyperthermia.com\/oncologic-hyperthermia-phase-3-trials\/\">H\u00fcpertermia terapeutiline integreerimine kaasaegsesse onkoloogiasse: III faasi uuringute ja metaanal\u00fc\u00fcside kriitiline anal\u00fc\u00fcs (OS, DFS, CR tulemusn\u00e4itajad)<\/a><\/strong><\/li>\n<\/ul>\n<\/div>\n<\/section>\n<section id=\"Scientific_Library\" style=\"margin-bottom: 60px;\">\n<h2 style=\"text-align: center; color: #003366; margin-bottom: 30px;\">Teadusartiklid: H\u00fcpertermia uurimine<\/h2>\n<div style=\"background: #fff; border-radius: 12px; border: 1px solid #eee; padding: 10px 25px;\">\n<ul style=\"list-style: none; padding-left: 0;\">\n<li style=\"padding: 15px 0; border-bottom: 1px solid #f0f0f0;\">\n<p style=\"margin: 0 0 5px 0;\">Regionaalne h\u00fcpertermia kombineerituna kiiritusraviga emakakaelav\u00e4hi korral: Rahvusvahelise Aatomienergiaagentuuri prospektiivne mitmekeskuseline randomiseeritud uuring<\/p>\n<p><a style=\"font-size: 0.9em; color: #0056b3; font-weight: bold;\" href=\"https:\/\/andromedic.it\/wp-content\/uploads\/2023\/02\/25_REG1.pdf\" target=\"_blank\" rel=\"noopener\">[ Laadi alla PDF ]<\/a><\/li>\n<li style=\"padding: 15px 0; border-bottom: 1px solid #f0f0f0;\">\n<p style=\"margin: 0 0 5px 0;\">Uus raadiosagedusliku h\u00fcpertermia (neotermia) strateegia kombineerituna operatsioonieelse kemoradioteraapiaga kaugelearenenud p\u00e4rasoolev\u00e4hi raviks: pilootuuring<\/p>\n<p><a style=\"font-size: 0.9em; color: #0056b3; font-weight: bold;\" href=\"https:\/\/andromedic.it\/wp-content\/uploads\/2023\/02\/24_Shoji_et_al-2015-Cancer_Medicine.pdf\" target=\"_blank\" rel=\"noopener\">[ Laadi alla PDF ]<\/a><\/li>\n<li style=\"padding: 15px 0; border-bottom: 1px solid #f0f0f0;\">\n<p style=\"margin: 0 0 5px 0;\">Lokaalse h\u00fcpertermia immuuns\u00fcsteemiga seotud m\u00f5jud maksav\u00e4higa patsientidel<\/p>\n<p><a style=\"font-size: 0.9em; color: #0056b3; font-weight: bold;\" href=\"https:\/\/andromedic.it\/wp-content\/uploads\/2023\/02\/23_Immune-related-Effects-of-Local-Hyperthermia-in-Patients-with-Primary-Liver-Cancer.pdf\" target=\"_blank\" rel=\"noopener\">[ Laadi alla PDF ]<\/a><\/li>\n<li style=\"padding: 15px 0; border-bottom: 1px solid #f0f0f0;\">\n<p style=\"margin: 0 0 5px 0;\">Taaskiiritus pluss regionaalne h\u00fcpertermia retsidiveeruva mittev\u00e4ikerakk-kopsuv\u00e4hi korral: potentsiaalne modaalsus pikaajalise elulemuse saavutamiseks valitud patsientidel<\/p>\n<p><a style=\"font-size: 0.9em; color: #0056b3; font-weight: bold;\" href=\"https:\/\/andromedic.it\/wp-content\/uploads\/2023\/02\/22_RE-1.pdf\" target=\"_blank\" rel=\"noopener\">[ Laadi alla PDF ]<\/a><\/li>\n<li style=\"padding: 15px 0; border-bottom: 1px solid #f0f0f0;\">\n<p style=\"margin: 0 0 5px 0;\">8 MHz raadiosageduslik mahtuvuslik regionaalne h\u00fcpertermia ja kiiritusravi III staadiumi mittev\u00e4ikerakk-kopsuv\u00e4hi korral: RF-v\u00e4ljundv\u00f5imsus korreleerub s\u00f6\u00f6gitorusisese temperatuuri ja kliiniliste tulemustega<\/p>\n<p><a style=\"font-size: 0.9em; color: #0056b3; font-weight: bold;\" href=\"https:\/\/andromedic.it\/wp-content\/uploads\/2023\/02\/20_RAD1.pdf\" target=\"_blank\" rel=\"noopener\">[ Laadi alla PDF ]<\/a><\/li>\n<li style=\"padding: 15px 0; border-bottom: 1px solid #f0f0f0;\">\n<p style=\"margin: 0 0 5px 0;\">Kogu rindkere piirkonna s\u00fcva regionaalne h\u00fcpertermia, kasutades 8 MHz raadiosageduslikku mahtuvuslikku soojendusseadet: seos RF-v\u00e4ljundv\u00f5imsuse ja s\u00f6\u00f6gitorusisese temperatuuri vahel (59 patsienti)<\/p>\n<p><a style=\"font-size: 0.9em; color: #0056b3; font-weight: bold;\" href=\"https:\/\/andromedic.it\/wp-content\/uploads\/2023\/02\/19_Deep-regional-hyperthermia-for-the-whole-thoracic-region-using-8-MHz-radiofrequency-capacitive-heating-device.pdf\" target=\"_blank\" rel=\"noopener\">[ Laadi alla PDF ]<\/a><\/li>\n<li style=\"padding: 15px 0; border-bottom: 1px solid #f0f0f0;\">\n<p style=\"margin: 0 0 5px 0;\">H\u00fcpertermia kombineerituna keemiaraviga patsientidel, kellel on j\u00e4\u00e4k- v\u00f5i retsidiveeruv s\u00f6\u00f6gitoruv\u00e4hk p\u00e4rast l\u00f5plikku kemoradioteraapiat<\/p>\n<p><a style=\"font-size: 0.9em; color: #0056b3; font-weight: bold;\" href=\"https:\/\/andromedic.it\/wp-content\/uploads\/2023\/02\/18_nishimura-oesophageal-cancer.pdf\" target=\"_blank\" rel=\"noopener\">[ Laadi alla PDF ]<\/a><\/li>\n<li style=\"padding: 15px 0; border-bottom: 1px solid #f0f0f0;\">\n<p style=\"margin: 0 0 5px 0;\">L\u00f5plik kiiritusravi pluss regionaalne h\u00fcpertermia keemiaraviga v\u00f5i ilma \u00fclemise sulkuse kasvajate korral: \u00fche keskuse 20-aastane kogemus<\/p>\n<p><a style=\"font-size: 0.9em; color: #0056b3; font-weight: bold;\" href=\"https:\/\/andromedic.it\/wp-content\/uploads\/2023\/02\/17_DEF1.pdf\" target=\"_blank\" rel=\"noopener\">[ Laadi alla PDF ]<\/a><\/li>\n<li style=\"padding: 15px 0; border-bottom: 1px solid #f0f0f0;\">\n<p style=\"margin: 0 0 5px 0;\">Operatsioonij\u00e4rgse intraperitoneaalse h\u00fcpertermokeemiaravi teostatavusuuring, kasutades raadiosageduslikku mahtuvuslikku soojenduss\u00fcsteemi kaugelearenenud maov\u00e4hi korral koos peritoneaalse levikuga<\/p>\n<p><a style=\"font-size: 0.9em; color: #0056b3; font-weight: bold;\" href=\"https:\/\/andromedic.it\/wp-content\/uploads\/2023\/02\/16_FEA1.pdf\" target=\"_blank\" rel=\"noopener\">[ Laadi alla PDF ]<\/a><\/li>\n<li style=\"padding: 15px 0; border-bottom: 1px solid #f0f0f0;\">\n<p style=\"margin: 0 0 5px 0;\">Kvaliteedi tagamise juhised pindmise h\u00fcpertermia kliiniliste uuringute jaoks (I ja II)<\/p>\n<p><a style=\"font-size: 0.9em; color: #0056b3; font-weight: bold;\" href=\"https:\/\/andromedic.it\/wp-content\/uploads\/2023\/02\/Quality-assurance-guidelines-for-superficial-hyperthermiaclinical-trials.pdf\" target=\"_blank\" rel=\"noopener\">[ Laadi alla PDF ]<\/a><\/li>\n<li style=\"padding: 15px 0; border-bottom: 1px solid #f0f0f0;\">\n<p style=\"margin: 0 0 5px 0;\">Kasvaja omaduste m\u00f5ju energia neeldumisele, temperatuuri kaardistamisele ja termilisele doosile 13,56 MHz raadiosagedusliku h\u00fcpertermia korral<\/p>\n<p><a style=\"font-size: 0.9em; color: #0056b3; font-weight: bold;\" href=\"https:\/\/andromedic.it\/wp-content\/uploads\/2023\/02\/12_EFF1.pdf\" target=\"_blank\" rel=\"noopener\">[ Laadi alla PDF ]<\/a><\/li>\n<li style=\"padding: 15px 0; border-bottom: 1px solid #f0f0f0;\">\n<p style=\"margin: 0 0 5px 0;\">H\u00fcpertermia kombineerituna kiiritusraviga lokaalselt levinud retsidiveeruva v\u00f5i metastaatilise haiguse korral<\/p>\n<p><a style=\"font-size: 0.9em; color: #0056b3; font-weight: bold;\" href=\"https:\/\/andromedic.it\/wp-content\/uploads\/2023\/02\/11_OP14_Maluta_Hyperthermia-combined-with-Radiotherapy-in-locally-advanced-recurrent-or-metastatic-disease-1.pdf\" target=\"_blank\" rel=\"noopener\">[ Laadi alla PDF ]<\/a><\/li>\n<li style=\"padding: 15px 0; border-bottom: 1px solid #f0f0f0;\">\n<p style=\"margin: 0 0 5px 0;\">Liigutatavate isolatsiooniplaatide kasulikkus s\u00fcvasoojendusalade optimeerimiseks regionaalse h\u00fcpertermia korral, kasutades mahtuvuslikult sidestatud soojendusmeetodit<\/p>\n<p><a style=\"font-size: 0.9em; color: #0056b3; font-weight: bold;\" href=\"https:\/\/andromedic.it\/wp-content\/uploads\/2023\/02\/10_THE1.pdf\" target=\"_blank\" rel=\"noopener\">[ Laadi alla PDF ]<\/a><\/li>\n<li style=\"padding: 15px 0; border-bottom: 1px solid #f0f0f0;\">\n<p style=\"margin: 0 0 5px 0;\">S\u00fcvakasvajate lokaalregionaalne h\u00fcpertermia mahtuvuslike ja kiirguslike s\u00fcsteemidega: simulatsiooniuuring<\/p>\n<p><a style=\"font-size: 0.9em; color: #0056b3; font-weight: bold;\" href=\"https:\/\/andromedic.it\/wp-content\/uploads\/2023\/02\/9_LOC1.pdf\" target=\"_blank\" rel=\"noopener\">[ Laadi alla PDF ]<\/a><\/li>\n<li style=\"padding: 15px 0; border-bottom: 1px solid #f0f0f0;\">\n<p style=\"margin: 0 0 5px 0;\">Bevatsizumaabi-p\u00f5hine keemiaravi kombineerituna s\u00fcva regionaalse mahtuvusliku h\u00fcpertermiaga metastaatilise v\u00e4higa patsientidel: pilootuuring<\/p>\n<p><a style=\"font-size: 0.9em; color: #0056b3; font-weight: bold;\" href=\"https:\/\/andromedic.it\/wp-content\/uploads\/2023\/02\/8_gadaleta-bevacizumab-HT.pdf\" target=\"_blank\" rel=\"noopener\">[ Laadi alla PDF ]<\/a><\/li>\n<li style=\"padding: 15px 0; border-bottom: 1px solid #f0f0f0;\">\n<p style=\"margin: 0 0 5px 0;\">Mahtuvusliku ja kiirgusliku pindmise h\u00fcpertermia soojendusomaduste v\u00f5rdlus<\/p>\n<p><a style=\"font-size: 0.9em; color: #0056b3; font-weight: bold;\" href=\"https:\/\/andromedic.it\/wp-content\/uploads\/2023\/02\/7_COM1.pdf\" target=\"_blank\" rel=\"noopener\">[ Laadi alla PDF ]<\/a><\/li>\n<li style=\"padding: 15px 0; border-bottom: 1px solid #f0f0f0;\">\n<p style=\"margin: 0 0 5px 0;\">Kvaliteedi tagamine: soovitatavad juhised ohutuks soojendamiseks mahtuvusliku soojendustehnikaga metallimplantaatidega patsientide raviks<\/p>\n<p><a style=\"font-size: 0.9em; color: #0056b3; font-weight: bold;\" href=\"https:\/\/andromedic.it\/wp-content\/uploads\/2023\/02\/6_QUAL1.pdf\" target=\"_blank\" rel=\"noopener\">[ Laadi alla PDF ]<\/a><\/li>\n<li style=\"padding: 15px 0; border-bottom: 1px solid #f0f0f0;\">\n<p style=\"margin: 0 0 5px 0;\">Termo-keemo-kiiritusravi kaugelearenenud sapiteede v\u00e4hi korral<\/p>\n<p><a style=\"font-size: 0.9em; color: #0056b3; font-weight: bold;\" href=\"https:\/\/andromedic.it\/wp-content\/uploads\/2023\/02\/5_kamisawa-bile-duct.pdf\" target=\"_blank\" rel=\"noopener\">[ Laadi alla PDF ]<\/a><\/li>\n<li style=\"padding: 15px 0; border-bottom: 1px solid #f0f0f0;\">\n<p style=\"margin: 0 0 5px 0;\">S\u00fcva regionaalse RF-mahtuvusliku h\u00fcpertermia numbriline mudel vaagnapiirkonna kasvajate korral<\/p>\n<p><a style=\"font-size: 0.9em; color: #0056b3; font-weight: bold;\" href=\"https:\/\/andromedic.it\/wp-content\/uploads\/2023\/02\/Numerical-model-for-deep-regional-RF-capacitive-hyperthermia-in-pelvic-tumors.pdf\" target=\"_blank\" rel=\"noopener\">[ Laadi alla PDF ]<\/a><\/li>\n<li style=\"padding: 15px 0; border-bottom: 1px solid #f0f0f0;\">\n<p style=\"margin: 0 0 5px 0;\">Mahtuvuslik h\u00fcpertermia n\u00e4ib parandavat valuvastust valulike luumetastaaside palliatiivse kiiritusravi ajal<\/p>\n<p><a style=\"font-size: 0.9em; color: #0056b3; font-weight: bold;\" href=\"https:\/\/andromedic.it\/wp-content\/uploads\/2023\/02\/1_DIEK1.pdf\" target=\"_blank\" rel=\"noopener\">[ Laadi alla PDF ]<\/a><\/li>\n<li style=\"padding: 15px 0; border-bottom: 1px solid #f0f0f0;\">\n<p style=\"margin: 0 0 5px 0;\">Kemoradioteraapia pluss h\u00fcpertermia ja suurdoosilise brahh\u00fcteraapia esialgsed tulemused lokaalselt levinud emakakaelav\u00e4hi korral<\/p>\n<p><a style=\"font-size: 0.9em; color: #0056b3; font-weight: bold;\" href=\"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/POSTER-HT-ESHO-2014-clarke.pdf\" target=\"_blank\" rel=\"noopener\">[ Laadi alla PDF ]<\/a><\/li>\n<li style=\"padding: 15px 0; border-bottom: 1px solid #f0f0f0;\">\n<p style=\"margin: 0 0 5px 0;\">Lokaalse s\u00fcvah\u00fcpertermia ravi teostatavus kombineerituna standardsete onkoloogiliste ravidega ja vastusemustrid<\/p>\n<p><a style=\"font-size: 0.9em; color: #0056b3; font-weight: bold;\" href=\"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/CTO-ExperiencianHipertermia-Las-Palmas-Marzo-2019.pdf\" target=\"_blank\" rel=\"noopener\">[ Laadi alla PDF ]<\/a><\/li>\n<li style=\"padding: 15px 0;\">\n<p style=\"margin: 0 0 5px 0;\">Kvasi-teostatavusuuring (juhtkontrolluuring), mis seostab s\u00fcva lokaalset h\u00fcpertermiat standardsete onkoloogiliste ravidega ja kirjeldab vastusemustrit<\/p>\n<p><a style=\"font-size: 0.9em; color: #0056b3; font-weight: bold;\" href=\"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/Protocolo-del-ensayo-MAG-HIP-2013-01-11-EN.pdf\" target=\"_blank\" rel=\"noopener\">[ Laadi alla PDF ]<\/a><\/li>\n<\/ul>\n<\/div>\n<\/section>\n<section id=\"Guidelines\" style=\"margin-bottom: 60px; background: #34495e; color: #fff; padding: 40px; border-radius: 12px;\">\n<div>\n<h3 style=\"text-align: center; border-bottom: 2px solid #white; padding-bottom: 15px; margin-bottom: 30px;\"><span style=\"color: #ffffff; background-color: #34495e; font-size: 20px;\">Kliinilise rakendamise ja kvaliteedi tagamise juhised<\/span><\/h3>\n<\/div>\n<div style=\"display: grid; grid-template-columns: repeat(auto-fit, minmax(280px, 1fr)); gap: 20px;\"><a style=\"color: #ecf0f1; text-decoration: none; padding: 15px; border: 1px solid #5d6d7e; border-radius: 8px; text-align: center;\" href=\"https:\/\/andromedic.it\/wp-content\/uploads\/2023\/02\/6_QUAL1.pdf\" target=\"_blank\" rel=\"noopener\">&#x2714;&#xfe0f; Metallimplantaatidega patsiendid<\/a><br \/>\n<a style=\"color: #ecf0f1; text-decoration: none; padding: 15px; border: 1px solid #5d6d7e; border-radius: 8px; text-align: center;\" href=\"https:\/\/andromedic.it\/wp-content\/uploads\/2023\/02\/Linee-guida-HT-.pdf\" target=\"_blank\" rel=\"noopener\">&#x2714;&#xfe0f; S\u00fcva regionaalse HT juhised<\/a><br \/>\n<a style=\"color: #ecf0f1; text-decoration: none; padding: 15px; border: 1px solid #5d6d7e; border-radius: 8px; text-align: center;\" href=\"https:\/\/andromedic.it\/wp-content\/uploads\/2023\/02\/Guide-to-the-use-of-hyperthermic-equipment-1-Capacitivelycoupled-heating.pdf\" target=\"_blank\" rel=\"noopener\">&#x2714;&#xfe0f; Seadme kasutusjuhend<\/a><br \/>\n<a style=\"color: #ecf0f1; text-decoration: none; padding: 15px; border: 1px solid #5d6d7e; border-radius: 8px; text-align: center;\" href=\"https:\/\/andromedic.it\/wp-content\/uploads\/2023\/02\/Quality-assurance-guidelines-for-superficial-hyperthermiaclinical-trials.pdf\" target=\"_blank\" rel=\"noopener\">&#x2714;&#xfe0f; Pindmise HT kvaliteedi tagamise juhend<\/a><\/div>\n<\/section>\n<footer style=\"text-align: center; border-top: 2px solid #eee; padding-top: 40px;\">\n<h3>Kas olete huvitatud kliiniliste uuringute \u00fcksikasjalikest tulemustest?<\/h3>\n<p>V\u00f5tke \u00fchendust meie ekspertidega, et saada t\u00e4ielik kliiniliste uuringute toimik t\u00e4iustatud onkoloogilise h\u00fcpertermiaseadme Andromedic HyDeep 600WM kohta.<\/p>\n<p><a style=\"background: #c0392b; color: #fff; padding: 15px 35px; border-radius: 30px; text-decoration: none; font-weight: bold; display: inline-block; margin-top: 20px; font-size: 1.1em;\" href=\"https:\/\/andromedichyperthermia.com\/et\/votke-uhendust-andromedic-eestiga\/\">K\u00fcsi kliinilist tuge<\/a><\/p>\n<\/footer>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Amplituudmoduleeritud RF-h\u00fcpertermia (mHT) kliinilised uuringud Andromedic HyDeep 600WM Onkoloogiline h\u00fcpertermiaseade on suunatud moduleeritud RF-h\u00fcpertermia onkoloogilise ravi nurgakivi. Tutvuge asjakohaste kliiniliste uuringute, ESHO posterite ja eelretsenseeritud tulemustega, mis kinnitavad lokaalregionaalse h\u00fcpertermia terapeutilisi eeliseid tugeva radiosensibilisaatori ja kemosensibilisaatorina. HyDeep 600WM mHT Modulaatne RF-h\u00fcpertermias\u00fcsteem t\u00f5endusp\u00f5hised eelised: S\u00fcnergistlik t\u00f5husus: Suurendab m\u00e4rkimisv\u00e4\u00e4rselt kasvaja vastuse m\u00e4\u00e4ra kombineerituna kiiritus- ja keemiaraviga. Elulemuse&hellip;<\/p>\n","protected":false},"author":1,"featured_media":1706,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"template-gutentor-full-width.php","meta":{"footnotes":""},"class_list":["post-3060","page","type-page","status-publish","has-post-thumbnail","hentry"],"_links":{"self":[{"href":"https:\/\/andromedichyperthermia.com\/et\/wp-json\/wp\/v2\/pages\/3060","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/andromedichyperthermia.com\/et\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/andromedichyperthermia.com\/et\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/andromedichyperthermia.com\/et\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/andromedichyperthermia.com\/et\/wp-json\/wp\/v2\/comments?post=3060"}],"version-history":[{"count":0,"href":"https:\/\/andromedichyperthermia.com\/et\/wp-json\/wp\/v2\/pages\/3060\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/andromedichyperthermia.com\/et\/wp-json\/wp\/v2\/media\/1706"}],"wp:attachment":[{"href":"https:\/\/andromedichyperthermia.com\/et\/wp-json\/wp\/v2\/media?parent=3060"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}